{"transactions":[{"id":1675832,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-20T02:01:56.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":6846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":6846,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6846},"source":{"system":"sec-edgar","filing":"0001209191-24-001977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001977/doc4.xml","form_type":"4"}},{"id":1675831,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-20T02:01:56.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":41078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024)."}],"balance_after":41078,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":41078},"source":{"system":"sec-edgar","filing":"0001209191-24-001977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001977/doc4.xml","form_type":"4"}},{"id":1679522,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-16T22:19:23.000Z","date":"2024-01-13","kind":"exercise","planned":false,"acquired":false,"shares":1289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":6675,"derivative":{"underlying":"Common Stock","underlying_shares":1289},"source":{"system":"sec-edgar","filing":"0001209191-24-001626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001626/doc4.xml","form_type":"4"}},{"id":1679521,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-16T22:19:23.000Z","date":"2024-01-13","kind":"exercise","planned":false,"acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":1656,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-24-001626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001626/doc4.xml","form_type":"4"}},{"id":1679520,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-01-16T22:19:23.000Z","date":"2024-01-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":756,"price":2.15,"value":1625.4,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":55907,"source":{"system":"sec-edgar","filing":"0001209191-24-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001626/doc4.xml","form_type":"4"}},{"id":1679519,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-01-16T22:19:23.000Z","date":"2024-01-13","kind":"exercise","planned":false,"acquired":true,"shares":1289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":56663,"source":{"system":"sec-edgar","filing":"0001209191-24-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001626/doc4.xml","form_type":"4"}},{"id":1679518,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-01-16T22:19:23.000Z","date":"2024-01-13","kind":"exercise","planned":false,"acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":55374,"source":{"system":"sec-edgar","filing":"0001209191-24-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001626/doc4.xml","form_type":"4"}},{"id":1759444,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-17T23:57:53.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":false,"shares":1932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":7964,"derivative":{"underlying":"Common Stock","underlying_shares":1932},"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759443,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-17T23:57:53.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":2208,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759442,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2023-10-17T23:57:53.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":42631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs were further subject to a time-based vesting schedule. The PSUs vested in full on the first anniversary of the grant date (July 25, 2023)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs were further subject to a time-based vesting schedule. The PSUs vested in full on the first anniversary of the grant date (July 25, 2023)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42631},"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759441,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-10-17T23:57:53.000Z","date":"2023-10-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":860,"price":0.72,"value":619.2,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":54822,"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759440,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-10-17T23:57:53.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":true,"shares":1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":55682,"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759439,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-10-17T23:57:53.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":53750,"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759438,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-10-17T23:57:53.000Z","date":"2023-07-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":14743,"price":1.51,"value":22261.93,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":53198,"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1759437,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-10-17T23:57:53.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":42631,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":67941,"source":{"system":"sec-edgar","filing":"0001209191-23-053030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123053030/doc4.xml","form_type":"4"}},{"id":1827407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-19T22:21:02.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (07/17/2023)."}],"balance_after":150000,"derivative":{"exercise_price":1.32,"expiration_date":"2033-07-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-042787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042787/doc4.xml","form_type":"4"}},{"id":1829142,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-17T21:51:13.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":false,"shares":1933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":9896,"derivative":{"underlying":"Common Stock","underlying_shares":1933},"source":{"system":"sec-edgar","filing":"0001209191-23-042479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042479/doc4.xml","form_type":"4"}},{"id":1829141,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-17T21:51:13.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":2760,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-23-042479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042479/doc4.xml","form_type":"4"}},{"id":1829140,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:13.000Z","date":"2023-07-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":860,"price":1.31,"value":1126.6,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":25310,"source":{"system":"sec-edgar","filing":"0001209191-23-042479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042479/doc4.xml","form_type":"4"}},{"id":1829139,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:13.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":true,"shares":1933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":26170,"source":{"system":"sec-edgar","filing":"0001209191-23-042479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042479/doc4.xml","form_type":"4"}},{"id":1829138,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:13.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":24237,"source":{"system":"sec-edgar","filing":"0001209191-23-042479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042479/doc4.xml","form_type":"4"}},{"id":1919228,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:27:19.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":11829,"derivative":{"underlying":"Common Stock","underlying_shares":1932},"source":{"system":"sec-edgar","filing":"0001209191-23-024498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024498/doc4.xml","form_type":"4"}},{"id":1919227,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:27:19.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":3312,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-23-024498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024498/doc4.xml","form_type":"4"}},{"id":1919226,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:19.000Z","date":"2023-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":860,"price":2.88,"value":2476.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":23685,"source":{"system":"sec-edgar","filing":"0001209191-23-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024498/doc4.xml","form_type":"4"}},{"id":1919225,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:19.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":24545,"source":{"system":"sec-edgar","filing":"0001209191-23-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024498/doc4.xml","form_type":"4"}},{"id":1919224,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:19.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":22613,"source":{"system":"sec-edgar","filing":"0001209191-23-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024498/doc4.xml","form_type":"4"}},{"id":2050101,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2023-01-20T22:09:01.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":42631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."}],"balance_after":42631,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42631},"source":{"system":"sec-edgar","filing":"0001209191-23-004301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123004301/doc4.xml","form_type":"4"}},{"id":2054174,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:35:19.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":1933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":13761,"derivative":{"underlying":"Common Stock","underlying_shares":1933},"source":{"system":"sec-edgar","filing":"0001209191-23-003561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003561/doc4.xml","form_type":"4"}},{"id":2054173,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:35:19.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":3864,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-23-003561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003561/doc4.xml","form_type":"4"}},{"id":2054172,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:35:19.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":1013,"price":3.17,"value":3211.21,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":22061,"source":{"system":"sec-edgar","filing":"0001209191-23-003561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003561/doc4.xml","form_type":"4"}},{"id":2054171,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:35:19.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":1933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":23074,"source":{"system":"sec-edgar","filing":"0001209191-23-003561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003561/doc4.xml","form_type":"4"}},{"id":2054170,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:35:19.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":21141,"source":{"system":"sec-edgar","filing":"0001209191-23-003561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003561/doc4.xml","form_type":"4"}},{"id":2136684,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:36:53.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":1932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":15694,"derivative":{"underlying":"Common Stock","underlying_shares":1932},"source":{"system":"sec-edgar","filing":"0001209191-22-053832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053832/doc4.xml","form_type":"4"}},{"id":2136683,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:36:53.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":4416,"derivative":{"underlying":"Common Stock","underlying_shares":553},"source":{"system":"sec-edgar","filing":"0001209191-22-053832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053832/doc4.xml","form_type":"4"}},{"id":2136682,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:53.000Z","date":"2022-10-13","kind":"tax_withholding","acquired":false,"shares":861,"price":3.76,"value":3237.36,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":20589,"source":{"system":"sec-edgar","filing":"0001209191-22-053832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053832/doc4.xml","form_type":"4"}},{"id":2136681,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:53.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":21450,"source":{"system":"sec-edgar","filing":"0001209191-22-053832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053832/doc4.xml","form_type":"4"}},{"id":2136680,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:53.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":553,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":19518,"source":{"system":"sec-edgar","filing":"0001209191-22-053832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053832/doc4.xml","form_type":"4"}},{"id":2201575,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-27T22:21:57.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":60902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022)."}],"balance_after":60902,"derivative":{"exercise_price":3.17,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":60902},"source":{"system":"sec-edgar","filing":"0001209191-22-043289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122043289/doc4.xml","form_type":"4"}},{"id":2207292,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:55:52.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":1933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":17626,"derivative":{"underlying":"Common Stock","underlying_shares":1933},"source":{"system":"sec-edgar","filing":"0001209191-22-042260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042260/doc4.xml","form_type":"4"}},{"id":2207291,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:55:52.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":4969,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-22-042260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042260/doc4.xml","form_type":"4"}},{"id":2207290,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:52.000Z","date":"2022-07-13","kind":"tax_withholding","acquired":false,"shares":860,"price":3.01,"value":2588.6,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":18965,"source":{"system":"sec-edgar","filing":"0001209191-22-042260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042260/doc4.xml","form_type":"4"}},{"id":2207289,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:52.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":1933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":19825,"source":{"system":"sec-edgar","filing":"0001209191-22-042260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042260/doc4.xml","form_type":"4"}},{"id":2207288,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:52.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17892,"source":{"system":"sec-edgar","filing":"0001209191-22-042260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042260/doc4.xml","form_type":"4"}},{"id":2296649,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:03:55.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":1932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":19559,"derivative":{"underlying":"Common Stock","underlying_shares":1932},"source":{"system":"sec-edgar","filing":"0001209191-22-024520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024520/doc4.xml","form_type":"4"}},{"id":2296648,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:03:55.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":5521,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-22-024520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024520/doc4.xml","form_type":"4"}},{"id":2296647,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:55.000Z","date":"2022-04-13","kind":"tax_withholding","acquired":false,"shares":860,"price":6.07,"value":5220.2,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":17340,"source":{"system":"sec-edgar","filing":"0001209191-22-024520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024520/doc4.xml","form_type":"4"}},{"id":2296646,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:55.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":1932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18200,"source":{"system":"sec-edgar","filing":"0001209191-22-024520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024520/doc4.xml","form_type":"4"}},{"id":2296645,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:55.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":16268,"source":{"system":"sec-edgar","filing":"0001209191-22-024520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024520/doc4.xml","form_type":"4"}},{"id":2435409,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:06:58.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":1933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":21491,"derivative":{"underlying":"Common Stock","underlying_shares":1933},"source":{"system":"sec-edgar","filing":"0001209191-22-003360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003360/doc4.xml","form_type":"4"}},{"id":2435408,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:06:58.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":6073,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-22-003360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003360/doc4.xml","form_type":"4"}},{"id":2435407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:06:58.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":966,"price":8.3,"value":8017.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":15716,"source":{"system":"sec-edgar","filing":"0001209191-22-003360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003360/doc4.xml","form_type":"4"}},{"id":2435406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:06:58.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":1933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":16682,"source":{"system":"sec-edgar","filing":"0001209191-22-003360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003360/doc4.xml","form_type":"4"}},{"id":2435405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:06:58.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14749,"source":{"system":"sec-edgar","filing":"0001209191-22-003360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003360/doc4.xml","form_type":"4"}},{"id":2542011,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:23:35.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":23424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":23424,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23424},"source":{"system":"sec-edgar","filing":"0001209191-21-060549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060549/doc4.xml","form_type":"4"}},{"id":2542010,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-15T20:23:35.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":13013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant."}],"balance_after":13013,"derivative":{"exercise_price":10.55,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":13013},"source":{"system":"sec-edgar","filing":"0001209191-21-060549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060549/doc4.xml","form_type":"4"}},{"id":2542009,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:23:35.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":6625,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-21-060549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060549/doc4.xml","form_type":"4"}},{"id":2542008,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:23:35.000Z","date":"2021-10-13","kind":"tax_withholding","acquired":false,"shares":191,"price":10.55,"value":2015.05,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":14197,"source":{"system":"sec-edgar","filing":"0001209191-21-060549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060549/doc4.xml","form_type":"4"}},{"id":2542007,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:23:35.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14388,"source":{"system":"sec-edgar","filing":"0001209191-21-060549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060549/doc4.xml","form_type":"4"}},{"id":2633542,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-15T20:48:11.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":7177,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-21-046788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046788/doc4.xml","form_type":"4"}},{"id":2633541,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:48:11.000Z","date":"2021-07-13","kind":"tax_withholding","acquired":false,"shares":191,"price":13.48,"value":2574.68,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":13836,"source":{"system":"sec-edgar","filing":"0001209191-21-046788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046788/doc4.xml","form_type":"4"}},{"id":2633540,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:48:11.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14027,"source":{"system":"sec-edgar","filing":"0001209191-21-046788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046788/doc4.xml","form_type":"4"}},{"id":2633539,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:48:11.000Z","date":"2021-04-30","kind":"other","acquired":true,"shares":1530,"price":13.8975,"value":21263.175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":13475,"source":{"system":"sec-edgar","filing":"0001209191-21-046788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046788/doc4.xml","form_type":"4"}},{"id":2748980,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T20:52:16.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":7729,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-21-026842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026842/doc4.xml","form_type":"4"}},{"id":2748979,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:52:16.000Z","date":"2021-04-13","kind":"tax_withholding","acquired":false,"shares":191,"price":16.66,"value":3182.06,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":11945,"source":{"system":"sec-edgar","filing":"0001209191-21-026842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026842/doc4.xml","form_type":"4"}},{"id":2748978,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:52:16.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12136,"source":{"system":"sec-edgar","filing":"0001209191-21-026842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026842/doc4.xml","form_type":"4"}},{"id":2906635,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-15T21:26:35.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":8281,"derivative":{"underlying":"Common Stock","underlying_shares":552},"source":{"system":"sec-edgar","filing":"0001209191-21-003794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003794/doc4.xml","form_type":"4"}},{"id":2906634,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:26:35.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":227,"price":18.16,"value":4122.32,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":11584,"source":{"system":"sec-edgar","filing":"0001209191-21-003794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003794/doc4.xml","form_type":"4"}},{"id":2906633,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:26:35.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11811,"source":{"system":"sec-edgar","filing":"0001209191-21-003794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003794/doc4.xml","form_type":"4"}},{"id":3006597,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-15T20:35:53.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":8833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."}],"balance_after":8833,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8833},"source":{"system":"sec-edgar","filing":"0001209191-20-054914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054914/doc4.xml","form_type":"4"}},{"id":3006596,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60498,"kind":"person","name":"Peraza Lisa","position":1,"cik":"0001828266","reported_name":"Peraza Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-15T20:35:53.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":103000,"derivative":{"exercise_price":15.72,"expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001209191-20-054914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054914/doc4.xml","form_type":"4"}}]}